GW Pharmaceuticals - Hot or Not

GW Pharmaceuticals (Nasdaq:GWPH) is a UK-based biopharmaceutical company with a cannabinoid product platform. It has a market cap of $2.7 billion, and is not profitable.. Guest Devin Shutte from The Robert Group and resident expert Paul Theron from Vestact decide whether GW Pharmaceuticals is hot or not.

[@derekmicah1182]

Time to buy NOW.

[@brandonl562]

The FDA recently unanimously approved Epidolex for approval from the FDA.

[@mirzaifitness7007]

what’s the name of the second company he mentioned at the end?

[@christopherdavis4123]

As far as smoking goes as a dear friend of mine tought me. I would rather smoke here than there. Did I mention he was a dear elder priest who smoked.